HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Santucci Selected Research

Hypersensitivity (Allergy)

3/2003Skin testing and hypersensitivity reactions to oxaliplatin.
2/2002IgE-mediated allergy to corn: a 50 kDa protein, belonging to the Reduced Soluble Proteins, is a major allergen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Santucci Research Topics

Disease

2Hypersensitivity (Allergy)
03/2003 - 02/2002
2Contact Dermatitis (Eczema, Contact)
01/2003 - 12/2000
2Food Hypersensitivity (Food Allergy)
02/2002 - 11/2001
2Asthma (Bronchial Asthma)
11/2001 - 12/2000
1Erythema Multiforme
03/2004
1Onychomycosis (Tinea Unguium)
03/2004
1Cytomegalovirus Infections (Inclusion Disease)
03/2004
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
11/2001
1Urticaria (Hives)
12/2000
1Dermatitis
12/2000
1Rhinitis
12/2000
1Cheilitis
10/2000

Drug/Important Bio-Agent (IBA)

3SaltsIBA
02/2002 - 12/2000
2Proteins (Proteins, Gene)FDA Link
02/2002 - 11/2001
2AllergensIBA
02/2002 - 11/2001
2Immunoglobulin E (IgE)IBA
02/2002 - 11/2001
1Terbinafine (Lamisil)FDA LinkGeneric
03/2004
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2003
1AntioxidantsIBA
01/2003
1Irritants (Vesicants)IBA
01/2003
1ImmunosorbentsIBA
02/2002
1Carrier Proteins (Binding Protein)IBA
02/2002
1alpha-AmylasesIBA
11/2001
1Trypsin InhibitorsIBA
11/2001
1HaptensIBA
12/2000
1ChloridesIBA
12/2000
1PlatinumIBA
12/2000
1AcidsIBA
12/2000
1RhodiumIBA
12/2000
1iridium chlorideIBA
12/2000
1SodiumIBA
12/2000
1tetrachloroplatinate (potassium tetrachloroplatinate)IBA
12/2000
1platinum tetrachlorideIBA
12/2000
1palladium chlorideIBA
12/2000
1ToothpastesIBA
10/2000

Therapy/Procedure

1Therapeutics
03/2004